S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
Barbara G. McClung, the Chief Legal Officer of Caribou Biosciences , Inc. (NASDAQ:CRBU), recently reported selling shares of the company. According to a recent filing, McClung sold 3,564 shares of common stock at a weighted average price of $1.35 per share on February 21, 2025. This transaction totaled approximately $4,811. The sale occurs as CRBU trades near its 52-week low of $1.22, down significantly from its high of $8.33.
The sale was conducted as part of a "sell to cover" transaction, aimed solely at satisfying tax withholding obligations related to the vesting of restricted stock units (RSUs). The transaction was executed under a Rule 10b5-1 trading plan, which was established before the 2023 amendments to the rule.
In addition to the sale, McClung acquired 37,500 shares of common stock on February 20, 2025, as part of RSUs that will vest in four equal annual installments starting February 20, 2026. She also received options to purchase 170,000 shares of common stock at an exercise price of $1.41 per share, which will vest over a 48-month period starting February 20, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.